The studies, published in the New England Journal of Medicine and The Lancet, were retracted shortly after publication, following an outcry from researchers who saw obvious flaws.
Instead of helping the scientific community, it misleads them.
DR NIRMAL--Misleading may not have been the intention , but avarice led to that inevitably. Difficult to apportion blames-- perhaps a short cut was adopted by the estimable authors to hog the limelight , by not garnering enough DATA to support their claim. The reputable journals were far to quick to publish again to stay in the limelight , and perhaps skipped or diluted the otherwise grueling peer review process!!
I feel, most of the blame will go on researchers. The first principle of research is being honest in publication. Big publishing houses are business organizations, they want money. There are many such instances everywhere like this but the entire onus is on author.
Authors are always accountable for the veracity of their data.
Despite many instances of research fraud there is still no way for the peer-review process to ascertain the validity of data. Therefore we have no choice but to trust researchers who must be held accountable for this.
I think the urgent to publish more and the greed of becoming famous during COVID19, has lead many of our scientists, especially early-career researchers, to intentionally or unintentionally commit scientific misconduct. So, I think many other COVID-related papers may be retracted within the following year. This is also true about journals, who desire more fame through publishing several papers regarding hot topics, which can be seen even one of the best journals, frequently retracts or corrects COVID19 papers. The current issue is, unfortunatley becoming famous has destroyed authors/publishers' conscience, particularly during Corona outbreak.
Not being in the medical-research community, I can only provide an outsider's view, but "researchers who saw obvious flaws" is a big red flag for the publication. Peer review is the mechanism for minimizing such flawed articles, and that is under the control of the publication.
DR NIRMAL--have a look at this link: https://www.nationalheraldindia.com/india/indian-origin-doctors-in-the-us-fight-charges-of-fake-research-based-on-fake-data?fbclid=IwAR1BFhYLhO0YO9_qTl328i-HembbnL0CeXJkAl_F8iEpwU7si-OBaGgvjSM
I remember very clearly some transitions that were not perfect. In 1988 and maybe a couple of years after, we had a secretary who typed our notes on a special typewriter with math symbols, and she was very fast and made very few errors.
With LaTeX came a transition such that the scientists do the typing, with plenty of mistakes as a result. And we're still there - and it is a very stable tool, too. The mistake that one may make is based on the fact that everything looks soooo elegant - one can be easily fooled to think what you typed is correct, just because it looks so good. That is a dangerous mirage!
What with the increase of "scholars" and the need to cater every one of them, it is now a jungle that you can get easily lost in - and I definitely see - since perhaps five-ten years - a clear distinction between mainstream scientists, working with scientific methods with known boundaries and established theory - and light-weight alternative tools whose success is determined by luck, more or less (although there are exception where theory can be built also there).
I realise that there are problems that are hard to attack with traditional theory, but I would much rather stay on the side of math and work towards building a bridge to the more "practical tools", than the other way 'round.
“Uncanny similarity of unique inserts in the 2019-nCoV spike protein to HIV-1 gp120 and Gag,” bioRxiv preprint published January 31, 2020 and withdrawn February 2, 2020. More context here.
“Epidemiological and clinical features of the 2019 novel coronavirus outbreak in China,” medRxiv preprint published February 11, 2020 and withdrawn February 21, 2020. More context here.
“Chinese medical staff request international medical assistance in fighting against COVID-19,” letter in The Lancet published February 24, 2020 and retracted February 26, 2020. More context here.
“Potential False-Positive Rate Among the ‘Asymptomatic Infected Individuals’ in Close Contacts of COVID-19 Patients,” paper in the Chinese Journal of Epidemiology published March 5, 2020 and retracted a few days later. More context here.
“An epidemiological investigation of 2019 novel coronavirus diseases through aerosol-borne transmission by public transport,” published in early March in Practical Preventive Medicine and retracted sometime in mid-April. More context here.
“First viral replication of Covid-19 identified in the peritoneal dialysis fluid,” published in Bulletin de la Dialyse à Domicile on April 13, 2020, retracted on April 20, 2020. Our coverage here.
“Hydroxychloroquine plus azithromycin: a potential interest in reducing in-hospital morbidity due to COVID-19 pneumonia (HI-ZY-COVID)?” preprint published on medRxiv, May 11, 2020, withdrawn on May 20, 2020. Our coverage here.
“From SARS-CoV to Wuhan 2019-nCoV Outbreak: Similarity of Early Epidemic and Prediction of Future Trends,” preprint posted on bioRxiv, January 25, 2020, withdrawn January 28, 2020.
“Analysis of Ten Microsecond simulation data of SARS-CoV-2 dimeric main protease,” preprint posted on bioRxiv, April 12, 2020, withdrawn April 16, 2020.
“Computational analysis suggests putative intermediate animal hosts of the SARS-CoV-2,” preprint posted on bioRxiv, April 5, 2020, withdrawn April 20, 2020.
“Mental health status and coping strategy of medical workers in China during The COVID-19 outbreak,” preprint posted on medRxiv, February 25, 2020, withdrawn March 7, 2020.
“Mortality of a pregnant patient diagnosed with COVID-19: A case report with clinical, radiological, and histopathological findings,” published in Travel Medicine and Infectious Disease on April 11, 2020, retracted on May 2, 2020. Our coverage here.
“Effectiveness of Surgical and Cotton Masks in Blocking SARS–CoV-2: A Controlled Comparison in 4 Patients,” published on April 6, 2020 in the Annals of Internal Medicine, retracted on June 1, 2020.
“Hydroxychloroquine or chloroquine with or without a macrolide for treatment of COVID-19: a multinational registry analysis,” published in The Lancet on May 22, 2020, subjected to an expression of concern on June 2 ,and retracted on June 4.
“Cardiovascular Disease, Drug Therapy, and Mortality in Covid-19,” published in the New England Journal of Medicine on May 1, 2020, subjected to an expression of concern on June 2, and retracted on June 4.
“Corona Virus Killed by Sound Vibrations Produced by Thali or Ghanti: A Potential Hypothesis,” published in Journal of Molecular Pharmaceuticals and Regulatory Affairs, dates of publication and retraction unknown.
“Clinical and Epidemiological Characteristics of 34 Children With 2019 Novel Coronavirus Infection in Shenzhen,” published in Zhonghua Er Ke Za Zhi on February 17, 2020, date of retraction unknown.
“COVID-19 Emergency Responders in FDA’s Center for Drug Evaluation and Research,” published sometime after April 6, 2020 in Journal of the American Pharmacists Association, date of retraction unknown.
“Managing college operations during the coronavirus outbreak,” published April 10, 2020 in Journal of the American Pharmacists Association, date of retraction unknown.
“Ivermectin in COVID-19 Related Critical Illness,” posted in April 2020 on SSRN, retracted sometime in May. Reporting from The Scientist here.
Temporarily retracted
“Experimental Treatment with Favipiravir for COVID-19: An Open-Label Control Study,” published in Engineering on March 18, 2020 and temporarily retracted, now back online, all without explanation.
“Should sexual practices be discouraged during the pandemic?” Journal of the American Academy of Dermatology, publication date unknown (accepted April 16), retracted on or around May 11, and replaced on an unknown date. Our coverage here.
Expressions of concern
“Hydroxychloroquine and azithromycin as a treatment of COVID-19: results of an open-label non-randomized clinical trial,” published in International Journal of Microbial Agents on March 20, 2020. More context here and here.
“SARS-CoV-2 infects T lymphocytes through its spike protein-mediated membrane fusion,” published April 7, 2020. Our coverage here.
Like Retraction Watch? You can make a tax-deductible contribution to support our work, follow us on Twitter, like us on Facebook, add us to your RSS reader, or subscribe to our daily digest. If you find a retraction that’s not in our database, you can let us know here. For comments or feedback, email us at [email protected].